Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 45.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 82,502 shares of the pharmacy operator’s stock after purchasing an additional 25,962 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Walgreens Boots Alliance were worth $794,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Brooklyn Investment Group lifted its position in Walgreens Boots Alliance by 21.1% during the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock valued at $44,000 after buying an additional 830 shares in the last quarter. First Financial Corp IN lifted its holdings in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 885 shares in the last quarter. Sequoia Financial Advisors LLC boosted its position in Walgreens Boots Alliance by 4.4% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock worth $226,000 after purchasing an additional 1,063 shares during the period. Lincluden Management Ltd. increased its holdings in Walgreens Boots Alliance by 0.4% in the 3rd quarter. Lincluden Management Ltd. now owns 264,644 shares of the pharmacy operator’s stock valued at $2,371,000 after purchasing an additional 1,074 shares in the last quarter. Finally, CWA Asset Management Group LLC raised its position in Walgreens Boots Alliance by 9.2% in the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock valued at $120,000 after purchasing an additional 1,084 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 6.1 %

NASDAQ:WBA opened at $9.36 on Wednesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company has a market capitalization of $8.09 billion, a price-to-earnings ratio of -0.91, a price-to-earnings-growth ratio of 1.26 and a beta of 0.65. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $22.96. The stock has a 50-day simple moving average of $10.24 and a 200 day simple moving average of $9.79.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same quarter last year, the firm earned $0.66 EPS. The business’s revenue was up 7.6% on a year-over-year basis. Sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on WBA shares. UBS Group upped their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. TD Cowen lowered their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, October 22nd. Bank of America boosted their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Truist Financial lowered their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Finally, Barclays boosted their price objective on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 16th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $13.19.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.